ID   CXCR4_RAT               Reviewed;         349 AA.
AC   O08565; F1LPN8; Q8VD47;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   10-OCT-2018, sequence version 2.
DT   24-JUL-2024, entry version 161.
DE   RecName: Full=C-X-C chemokine receptor type 4;
DE            Short=CXC-R4;
DE            Short=CXCR-4;
DE   AltName: Full=Fusin;
DE   AltName: Full=Leukocyte-derived seven transmembrane domain receptor;
DE            Short=LESTR;
DE   AltName: Full=Stromal cell-derived factor 1 receptor;
DE            Short=SDF-1 receptor;
DE   AltName: CD_antigen=CD184;
GN   Name=Cxcr4; Synonyms=Cmkar4;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Wistar; TISSUE=Spleen;
RA   Harrison J.K., Salafranca M.N.;
RT   "Molecular cloning of rat CXCR4.";
RL   Submitted (MAR-1997) to the EMBL/GenBank/DDBJ databases.
RN   [2] {ECO:0000312|EMBL:AAL47855.1}
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Holtzman {ECO:0000312|EMBL:AAL47855.1};
RC   TISSUE=Brain {ECO:0000312|EMBL:AAL47855.1};
RA   Simen A.A., Miller R.J.;
RT   "Chemokine regulation of neuronal signaling and gp120 neurotoxicity.";
RL   Submitted (NOV-2001) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Thymus {ECO:0000312|EMBL:AAH89804.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Receptor for the C-X-C chemokine CXCL12/SDF-1 that transduces
CC       a signal by increasing intracellular calcium ion levels and enhancing
CC       MAPK1/MAPK3 activation. Involved in the AKT signaling cascade (By
CC       similarity). Plays a role in regulation of cell migration, e.g. during
CC       wound healing. Acts as a receptor for extracellular ubiquitin; leading
CC       to enhanced intracellular calcium ions and reduced cellular cAMP
CC       levels. Binds bacterial lipopolysaccharide (LPS) et mediates LPS-
CC       induced inflammatory response, including TNF secretion by monocytes (By
CC       similarity). Involved in hematopoiesis and in cardiac ventricular
CC       septum formation. Also plays an essential role in vascularization of
CC       the gastrointestinal tract, probably by regulating vascular branching
CC       and/or remodeling processes in endothelial cells. Involved in
CC       cerebellar development. In the CNS, could mediate hippocampal-neuron
CC       survival (By similarity). {ECO:0000250|UniProtKB:P61073,
CC       ECO:0000250|UniProtKB:P70658}.
CC   -!- SUBUNIT: Monomer. Can form homodimers. Interacts with CD164. Interacts
CC       with ARRB2; the interaction is dependent on the C-terminal
CC       phosphorylation of CXCR4 and allows activation of MAPK1 and MAPK3.
CC       Interacts with ARR3; the interaction is dependent on the C-terminal
CC       phosphorylation of CXCR4 and modulates calcium mobilization. Interacts
CC       with RNF113A; the interaction, enhanced by CXCL12, promotes CXCR4
CC       ubiquitination and subsequent degradation. Interacts (via the
CC       cytoplasmic C-terminal) with ITCH (via the WW domains I and II); the
CC       interaction, enhanced by CXCL12, promotes CXCR4 ubiquitination and
CC       leads to its degradation. Interacts with extracellular ubiquitin.
CC       Interacts with DBN1; this interaction is enhanced by antigenic
CC       stimulation. Following LPS binding, may form a complex with GDF5,
CC       HSP90AA1 and HSPA8. {ECO:0000250|UniProtKB:P61073}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P61073};
CC       Multi-pass membrane protein {ECO:0000250|UniProtKB:P61073}. Cell
CC       junction {ECO:0000250}. Early endosome {ECO:0000250}. Late endosome
CC       {ECO:0000250}. Lysosome {ECO:0000250}. Note=In unstimulated cells,
CC       diffuse pattern on plasma membrane. On agonist stimulation, colocalizes
CC       with ITCH at the plasma membrane where it becomes ubiquitinated (By
CC       similarity). In the presence of antigen, distributes to the
CC       immunological synapse forming at the T-cell-APC contact area, where it
CC       localizes at the peripheral and distal supramolecular activation
CC       cluster (SMAC) (By similarity). {ECO:0000250}.
CC   -!- PTM: Phosphorylated on agonist stimulation. Rapidly phosphorylated on
CC       serine and threonine residues in the C-terminal. Phosphorylation at
CC       Ser-321 and Ser-322 leads to recruitment of ITCH, ubiquitination and
CC       protein degradation. {ECO:0000250|UniProtKB:P61073}.
CC   -!- PTM: Ubiquitinated after ligand binding, leading to its degradation.
CC       Ubiquitinated by ITCH at the cell membrane on agonist stimulation. The
CC       ubiquitin-dependent mechanism, endosomal sorting complex required for
CC       transport (ESCRT), then targets CXCR4 for lysosomal degradation. This
CC       process is dependent also on prior Ser-/Thr-phosphorylation in the C-
CC       terminal of CXCR4. Also binding of ARRB1 to STAM negatively regulates
CC       CXCR4 sorting to lysosomes though modulating ubiquitination of SFR5S.
CC       {ECO:0000250|UniProtKB:P61073}.
CC   -!- PTM: Sulfation is required for efficient binding of CXCL12/SDF-1alpha
CC       and promotes its dimerization. {ECO:0000250|UniProtKB:P61073}.
CC   -!- PTM: O- and N-glycosylated. N-glycosylation can mask coreceptor
CC       function. The O-glycosylation chondroitin sulfate attachment does not
CC       affect interaction with CXCL12/SDF-1alpha nor its coreceptor activity.
CC       {ECO:0000250|UniProtKB:P61073}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U90610; AAB50408.1; -; mRNA.
DR   EMBL; AF452185; AAL47855.1; -; mRNA.
DR   EMBL; AABR07020898; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH473958; EDM09871.1; -; Genomic_DNA.
DR   EMBL; BC089804; AAH89804.1; -; mRNA.
DR   RefSeq; NP_071541.2; NM_022205.3.
DR   AlphaFoldDB; O08565; -.
DR   SMR; O08565; -.
DR   IntAct; O08565; 5.
DR   MINT; O08565; -.
DR   STRING; 10116.ENSRNOP00000005143; -.
DR   BindingDB; O08565; -.
DR   ChEMBL; CHEMBL5556; -.
DR   DrugCentral; O08565; -.
DR   GuidetoPHARMACOLOGY; 71; -.
DR   GlyCosmos; O08565; 2 sites, No reported glycans.
DR   GlyGen; O08565; 2 sites.
DR   PhosphoSitePlus; O08565; -.
DR   PaxDb; 10116-ENSRNOP00000005143; -.
DR   Ensembl; ENSRNOT00000005143.7; ENSRNOP00000005143.5; ENSRNOG00000003866.8.
DR   Ensembl; ENSRNOT00055035326; ENSRNOP00055028633; ENSRNOG00055020692.
DR   Ensembl; ENSRNOT00060032428; ENSRNOP00060026438; ENSRNOG00060018809.
DR   Ensembl; ENSRNOT00065015277; ENSRNOP00065011475; ENSRNOG00065009543.
DR   GeneID; 60628; -.
DR   KEGG; rno:60628; -.
DR   UCSC; RGD:620465; rat.
DR   AGR; RGD:620465; -.
DR   CTD; 7852; -.
DR   RGD; 620465; Cxcr4.
DR   eggNOG; KOG3656; Eukaryota.
DR   GeneTree; ENSGT01050000244848; -.
DR   HOGENOM; CLU_009579_8_3_1; -.
DR   InParanoid; O08565; -.
DR   OMA; GDYEEPC; -.
DR   OrthoDB; 4062414at2759; -.
DR   PhylomeDB; O08565; -.
DR   Reactome; R-RNO-380108; Chemokine receptors bind chemokines.
DR   Reactome; R-RNO-418594; G alpha (i) signalling events.
DR   PRO; PR:O08565; -.
DR   Proteomes; UP000002494; Chromosome 13.
DR   Proteomes; UP000234681; Chromosome 13.
DR   Bgee; ENSRNOG00000003866; Expressed in thymus and 20 other cell types or tissues.
DR   ExpressionAtlas; O08565; baseline and differential.
DR   GO; GO:0031252; C:cell leading edge; ISO:RGD.
DR   GO; GO:0009986; C:cell surface; ISO:RGD.
DR   GO; GO:0005911; C:cell-cell junction; ISO:RGD.
DR   GO; GO:0031410; C:cytoplasmic vesicle; ISO:RGD.
DR   GO; GO:0005769; C:early endosome; ISS:UniProtKB.
DR   GO; GO:0005768; C:endosome; IDA:RGD.
DR   GO; GO:0009897; C:external side of plasma membrane; ISO:RGD.
DR   GO; GO:0030426; C:growth cone; ISO:RGD.
DR   GO; GO:0005770; C:late endosome; ISS:UniProtKB.
DR   GO; GO:0005764; C:lysosome; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0032991; C:protein-containing complex; ISO:RGD.
DR   GO; GO:0003779; F:actin binding; ISO:RGD.
DR   GO; GO:0019957; F:C-C chemokine binding; ISO:RGD.
DR   GO; GO:0016493; F:C-C chemokine receptor activity; IBA:GO_Central.
DR   GO; GO:0016494; F:C-X-C chemokine receptor activity; TAS:RGD.
DR   GO; GO:0038147; F:C-X-C motif chemokine 12 receptor activity; ISS:UniProtKB.
DR   GO; GO:0032027; F:myosin light chain binding; ISO:RGD.
DR   GO; GO:0036094; F:small molecule binding; IMP:RGD.
DR   GO; GO:0043130; F:ubiquitin binding; ISO:RGD.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; ISO:RGD.
DR   GO; GO:0035904; P:aorta development; ISO:RGD.
DR   GO; GO:0043534; P:blood vessel endothelial cell migration; ISO:RGD.
DR   GO; GO:0007420; P:brain development; ISO:RGD.
DR   GO; GO:0001569; P:branching involved in blood vessel morphogenesis; ISO:RGD.
DR   GO; GO:0019722; P:calcium-mediated signaling; ISO:RGD.
DR   GO; GO:0060048; P:cardiac muscle contraction; IMP:RGD.
DR   GO; GO:0060326; P:cell chemotaxis; IBA:GO_Central.
DR   GO; GO:0016477; P:cell migration; IMP:RGD.
DR   GO; GO:0071345; P:cellular response to cytokine stimulus; ISS:UniProtKB.
DR   GO; GO:0071417; P:cellular response to organonitrogen compound; IPI:RGD.
DR   GO; GO:0071466; P:cellular response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0038160; P:CXCL12-activated CXCR4 signaling pathway; ISS:UniProtKB.
DR   GO; GO:0050966; P:detection of mechanical stimulus involved in sensory perception of pain; IMP:RGD.
DR   GO; GO:0050965; P:detection of temperature stimulus involved in sensory perception of pain; IMP:RGD.
DR   GO; GO:0045446; P:endothelial cell differentiation; IMP:RGD.
DR   GO; GO:0061154; P:endothelial tube morphogenesis; IMP:RGD.
DR   GO; GO:0002064; P:epithelial cell development; IMP:RGD.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; ISO:RGD.
DR   GO; GO:0048699; P:generation of neurons; ISO:RGD.
DR   GO; GO:0007281; P:germ cell development; ISO:RGD.
DR   GO; GO:0008354; P:germ cell migration; ISO:RGD.
DR   GO; GO:0035701; P:hematopoietic stem cell migration; ISO:RGD.
DR   GO; GO:0006955; P:immune response; IBA:GO_Central.
DR   GO; GO:0001822; P:kidney development; ISO:RGD.
DR   GO; GO:0008045; P:motor neuron axon guidance; ISO:RGD.
DR   GO; GO:0043217; P:myelin maintenance; ISO:RGD.
DR   GO; GO:0061351; P:neural precursor cell proliferation; ISO:RGD.
DR   GO; GO:0022008; P:neurogenesis; IMP:RGD.
DR   GO; GO:0001764; P:neuron migration; IDA:RGD.
DR   GO; GO:0008038; P:neuron recognition; IEP:RGD.
DR   GO; GO:0030316; P:osteoclast differentiation; HEP:RGD.
DR   GO; GO:0090280; P:positive regulation of calcium ion import; ISO:RGD.
DR   GO; GO:0030335; P:positive regulation of cell migration; IMP:RGD.
DR   GO; GO:0050921; P:positive regulation of chemotaxis; IMP:RGD.
DR   GO; GO:0120162; P:positive regulation of cold-induced thermogenesis; ISS:YuBioLab.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IBA:GO_Central.
DR   GO; GO:1903861; P:positive regulation of dendrite extension; IMP:RGD.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISO:RGD.
DR   GO; GO:2000448; P:positive regulation of macrophage migration inhibitory factor signaling pathway; ISO:RGD.
DR   GO; GO:1905322; P:positive regulation of mesenchymal stem cell migration; IMP:RGD.
DR   GO; GO:0050769; P:positive regulation of neurogenesis; IMP:RGD.
DR   GO; GO:0048714; P:positive regulation of oligodendrocyte differentiation; ISO:RGD.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; ISO:RGD.
DR   GO; GO:0035470; P:positive regulation of vascular wound healing; IMP:RGD.
DR   GO; GO:1904018; P:positive regulation of vasculature development; ISO:RGD.
DR   GO; GO:0051924; P:regulation of calcium ion transport; IMP:RGD.
DR   GO; GO:0030155; P:regulation of cell adhesion; ISO:RGD.
DR   GO; GO:0030334; P:regulation of cell migration; ISO:RGD.
DR   GO; GO:0050920; P:regulation of chemotaxis; IMP:RGD.
DR   GO; GO:2001222; P:regulation of neuron migration; ISO:RGD.
DR   GO; GO:0043067; P:regulation of programmed cell death; IMP:RGD.
DR   GO; GO:0050792; P:regulation of viral process; IDA:RGD.
DR   GO; GO:0014823; P:response to activity; IEP:RGD.
DR   GO; GO:0001666; P:response to hypoxia; ISO:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IMP:RGD.
DR   GO; GO:1901327; P:response to tacrolimus; IPI:RGD.
DR   GO; GO:1990478; P:response to ultrasound; IEP:RGD.
DR   GO; GO:0042098; P:T cell proliferation; ISO:RGD.
DR   GO; GO:0022029; P:telencephalon cell migration; IMP:RGD.
DR   GO; GO:0003281; P:ventricular septum development; ISO:RGD.
DR   CDD; cd15179; 7tmA_CXCR4; 1.
DR   Gene3D; 1.20.1070.10; Rhodopsin 7-helix transmembrane proteins; 1.
DR   InterPro; IPR022726; Chemokine_CXCR4_N_dom.
DR   InterPro; IPR000355; Chemokine_rcpt.
DR   InterPro; IPR001277; CXCR4/ACKR2.
DR   InterPro; IPR050119; GPCR1.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   PANTHER; PTHR10489:SF594; C-X-C CHEMOKINE RECEPTOR TYPE 4; 1.
DR   PANTHER; PTHR10489; CELL ADHESION MOLECULE; 1.
DR   Pfam; PF00001; 7tm_1; 1.
DR   Pfam; PF12109; CXCR4_N; 1.
DR   PRINTS; PR00657; CCCHEMOKINER.
DR   PRINTS; PR00645; CXCCHMKINER4.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   SUPFAM; SSF81321; Family A G protein-coupled receptor-like; 1.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   2: Evidence at transcript level;
KW   Cell junction; Cell membrane; Disulfide bond; Endosome;
KW   G-protein coupled receptor; Glycoprotein; Isopeptide bond; Lysosome;
KW   Membrane; Phosphoprotein; Proteoglycan; Receptor; Reference proteome;
KW   Sulfation; Transducer; Transmembrane; Transmembrane helix; Ubl conjugation.
FT   CHAIN           1..349
FT                   /note="C-X-C chemokine receptor type 4"
FT                   /id="PRO_0000069358"
FT   TOPO_DOM        1..35
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        36..60
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000250|UniProtKB:P61073"
FT   TOPO_DOM        61..74
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        75..96
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000250|UniProtKB:P61073"
FT   TOPO_DOM        97..107
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        108..127
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000250|UniProtKB:P61073"
FT   TOPO_DOM        128..151
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        152..171
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000250|UniProtKB:P61073"
FT   TOPO_DOM        172..192
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        193..213
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000250|UniProtKB:P61073"
FT   TOPO_DOM        214..238
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        239..258
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000250|UniProtKB:P61073"
FT   TOPO_DOM        259..279
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        280..299
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000250|UniProtKB:P61073"
FT   TOPO_DOM        300..349
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   REGION          1..23
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1..18
FT                   /note="Important for chemokine binding and signaling"
FT                   /evidence="ECO:0000250"
FT   REGION          91..94
FT                   /note="Chemokine binding"
FT                   /evidence="ECO:0000250"
FT   REGION          110..114
FT                   /note="Chemokine binding"
FT                   /evidence="ECO:0000250"
FT   REGION          132..144
FT                   /note="Involved in dimerization; when bound to chemokine"
FT                   /evidence="ECO:0000250"
FT   REGION          183..187
FT                   /note="Chemokine binding, important for signaling"
FT                   /evidence="ECO:0000250"
FT   REGION          188..207
FT                   /note="Involved in dimerization"
FT                   /evidence="ECO:0000250"
FT   REGION          263..265
FT                   /note="Involved in dimerization"
FT                   /evidence="ECO:0000250"
FT   REGION          325..349
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           130..132
FT                   /note="Important for signaling"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        1..15
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        332..349
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   SITE            168
FT                   /note="Chemokine binding"
FT                   /evidence="ECO:0000250"
FT   SITE            285
FT                   /note="Chemokine binding"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         9
FT                   /note="Sulfotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P61073"
FT   MOD_RES         18
FT                   /note="Sulfotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P61073"
FT   MOD_RES         316
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P61073"
FT   MOD_RES         318
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P61073"
FT   MOD_RES         321
FT                   /note="Phosphoserine; by PKC and GRK6"
FT                   /evidence="ECO:0000250|UniProtKB:P61073"
FT   MOD_RES         322
FT                   /note="Phosphoserine; by PKC and GRK6"
FT                   /evidence="ECO:0000250|UniProtKB:P61073"
FT   MOD_RES         327
FT                   /note="Phosphoserine; by GRK6"
FT                   /evidence="ECO:0000250|UniProtKB:P61073"
FT   MOD_RES         336
FT                   /note="Phosphoserine; by GRK6"
FT                   /evidence="ECO:0000250|UniProtKB:P61073"
FT   MOD_RES         345
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P61073"
FT   MOD_RES         348
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P61073"
FT   CARBOHYD        8
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        15
FT                   /note="O-linked (Xyl...) (chondroitin sulfate) serine"
FT                   /evidence="ECO:0000250|UniProtKB:P61073"
FT   DISULFID        25..271
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
FT   DISULFID        106..183
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
FT   CROSSLNK        328
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:P61073"
FT   CONFLICT        143..144
FT                   /note="RP -> SA (in Ref. 1; AAB50408)"
SQ   SEQUENCE   349 AA;  39429 MW;  09D19860D3D2CB8A CRC64;
     MEIYTSDNYS EEVGSGDYDS NKEPCFRDEN ENFNRIFLPT IYFIIFLTGI VGNGLVILVM
     GYQKKLRSMT DKYRLHLSVA DLLFVITLPF WAVDAMADWY FGKFLCKAVH IIYTVNLYSS
     VLILAFISLD RYLAIVHATN SQRPRKLLAE KAVYVGVWIP ALLLTIPDII FADVSQGDGR
     YICDRLYPDS LWMVVFQFQH IMVGLILPGI VILSCYCIII SKLSHSKGHQ KRKALKTTVI
     LILAFFACWL PYYVGISIDS FILLEVIKQG CEFESVVHKW ISITEALAFF HCCLNPILYA
     FLGAKFKSSA QHALNSMSRG SSLKILSKGK RGGHSSVSTE SESSSFHSS
//
